Cargando…
Probiotics and Atopic Dermatitis: An Overview
Atopic dermatitis (AD) is a common, recurrent, chronic inflammatory skin disease that is a cause of considerable economic and social burden. Its prevalence varies substantially among different countries with an incidence rate proclaimed to reach up to 20% of children in developed countries and conti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828648/ https://www.ncbi.nlm.nih.gov/pubmed/27148196 http://dx.doi.org/10.3389/fmicb.2016.00507 |
_version_ | 1782426626007498752 |
---|---|
author | Rather, Irfan A. Bajpai, Vivek K. Kumar, Sanjay Lim, Jeongheui Paek, Woon K. Park, Yong-Ha |
author_facet | Rather, Irfan A. Bajpai, Vivek K. Kumar, Sanjay Lim, Jeongheui Paek, Woon K. Park, Yong-Ha |
author_sort | Rather, Irfan A. |
collection | PubMed |
description | Atopic dermatitis (AD) is a common, recurrent, chronic inflammatory skin disease that is a cause of considerable economic and social burden. Its prevalence varies substantially among different countries with an incidence rate proclaimed to reach up to 20% of children in developed countries and continues to escalate in developing nations. This increased rate of incidence has changed the focus of research on AD toward epidemiology, prevention, and treatment. The effects of probiotics in the prevention and treatment of AD remain elusive. However, evidence from different research groups show that probiotics could have positive effect on AD treatment, if any, that depend on multiple factors, such as specific probiotic strains, time of administration (onset time), duration of exposure, and dosage. However, till date we still lack strong evidence to advocate the use of probiotics in the treatment of AD, and questions remain to be answered considering its clinical use in future. Based on updated information, the processes that facilitate the development of AD and the topic of the administration of probiotics are addressed in this review. |
format | Online Article Text |
id | pubmed-4828648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-48286482016-05-04 Probiotics and Atopic Dermatitis: An Overview Rather, Irfan A. Bajpai, Vivek K. Kumar, Sanjay Lim, Jeongheui Paek, Woon K. Park, Yong-Ha Front Microbiol Microbiology Atopic dermatitis (AD) is a common, recurrent, chronic inflammatory skin disease that is a cause of considerable economic and social burden. Its prevalence varies substantially among different countries with an incidence rate proclaimed to reach up to 20% of children in developed countries and continues to escalate in developing nations. This increased rate of incidence has changed the focus of research on AD toward epidemiology, prevention, and treatment. The effects of probiotics in the prevention and treatment of AD remain elusive. However, evidence from different research groups show that probiotics could have positive effect on AD treatment, if any, that depend on multiple factors, such as specific probiotic strains, time of administration (onset time), duration of exposure, and dosage. However, till date we still lack strong evidence to advocate the use of probiotics in the treatment of AD, and questions remain to be answered considering its clinical use in future. Based on updated information, the processes that facilitate the development of AD and the topic of the administration of probiotics are addressed in this review. Frontiers Media S.A. 2016-04-12 /pmc/articles/PMC4828648/ /pubmed/27148196 http://dx.doi.org/10.3389/fmicb.2016.00507 Text en Copyright © 2016 Rather, Bajpai, Kumar, Lim, Paek and Park. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Rather, Irfan A. Bajpai, Vivek K. Kumar, Sanjay Lim, Jeongheui Paek, Woon K. Park, Yong-Ha Probiotics and Atopic Dermatitis: An Overview |
title | Probiotics and Atopic Dermatitis: An Overview |
title_full | Probiotics and Atopic Dermatitis: An Overview |
title_fullStr | Probiotics and Atopic Dermatitis: An Overview |
title_full_unstemmed | Probiotics and Atopic Dermatitis: An Overview |
title_short | Probiotics and Atopic Dermatitis: An Overview |
title_sort | probiotics and atopic dermatitis: an overview |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828648/ https://www.ncbi.nlm.nih.gov/pubmed/27148196 http://dx.doi.org/10.3389/fmicb.2016.00507 |
work_keys_str_mv | AT ratherirfana probioticsandatopicdermatitisanoverview AT bajpaivivekk probioticsandatopicdermatitisanoverview AT kumarsanjay probioticsandatopicdermatitisanoverview AT limjeongheui probioticsandatopicdermatitisanoverview AT paekwoonk probioticsandatopicdermatitisanoverview AT parkyongha probioticsandatopicdermatitisanoverview |